Keywords: AstraZeneca, Faslodex, UK, NICE

UK’s NICE says no to AstraZeneca breast cancer drug Faslodex

Article | 10 November 2011

Print This

There was negative news this morning for Anglo-Swedish drug major AstraZeneca (LSE: AZN), when the UK’s the National ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in